Literature DB >> 23136879

Psychopathological long-term outcome of schizophrenia -- a review.

F U Lang1, M Kösters, S Lang, T Becker, M Jäger.   

Abstract

OBJECTIVE: In the past, the comparability of empirical studies that examined the course and outcome of schizophrenia was limited by their use of different diagnostic systems. Focussing on the psychopathological long-term outcome, the present article aims to review follow-up studies that used modern operationalized diagnostic criteria for schizophrenia (DSM-III, DSM-III-R, DSM-IV and ICD-10).
METHOD: We searched MEDLINE, the Cochrane Central Register of Controlled Trials, EMBASE, PsycINFO and PSYNDEX for relevant studies up to the year 2011. Twenty-one studies were included in the final analysis.
RESULTS: The long-term outcome of schizophrenia was heterogeneous and included full remissions as well as severe chronic states. Schizophrenia, however, showed a considerably more unfavourable outcome than other diagnostic groups such as schizoaffective or affective disorders. Psychopathological symptoms remained relatively stable in the course of illness. Several predictors for a poor outcome were identified, such as male gender or pronounced negative symptoms.
CONCLUSION: Recent studies using modern diagnostic systems largely confirm the results of earlier studies. Current diagnostic criteria for schizophrenia identify a heterogeneous sample of patients. The influence of therapeutic interventions on long-term outcome remains unclear.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23136879     DOI: 10.1111/acps.12030

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  26 in total

1.  Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders.

Authors:  Nikolaos Koutsouleris; Christos Davatzikos; Stefan Borgwardt; Christian Gaser; Ronald Bottlender; Thomas Frodl; Peter Falkai; Anita Riecher-Rössler; Hans-Jürgen Möller; Maximilian Reiser; Christos Pantelis; Eva Meisenzahl
Journal:  Schizophr Bull       Date:  2013-10-13       Impact factor: 9.306

2.  Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Tara Kingston; Paul J Scully; David J Browne; Patrizia A Baldwin; Anthony Kinsella; Eadbhard O'Callaghan; Vincent Russell; John L Waddington
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

3.  Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis.

Authors:  Kenji Sakuma; Shinji Matsunaga; Ikuo Nomura; Makoto Okuya; Taro Kishi; Nakao Iwata
Journal:  Psychopharmacology (Berl)       Date:  2018-05-22       Impact factor: 4.530

4.  A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study.

Authors:  Yange Li; Lei Zhang; Yan Zhang; Hui Wen; Jingjing Huang; Yifeng Shen; Huafang Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-03-19       Impact factor: 2.570

5.  Association between depression in chronic phase and future clinical outcome of patients with schizophrenia.

Authors:  Yuto Yamada; Yusuke Yamauchi; Shinji Sakamoto; Masaki Fujiwara; Yuko Okahisa; Soshi Takao; Manabu Takaki; Norihito Yamada
Journal:  Psychopharmacology (Berl)       Date:  2022-02-21       Impact factor: 4.530

6.  Long-Term Outcomes of First-Admission Psychosis: A Naturalistic 21-Year Follow-Up Study of Symptomatic, Functional and Personal Recovery and Their Baseline Predictors.

Authors:  Victor Peralta; Elena García de Jalón; Lucía Moreno-Izco; David Peralta; Lucía Janda; Ana M Sánchez-Torres; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

7.  Neurobiological Divergence of the Positive and Negative Schizophrenia Subtypes Identified on a New Factor Structure of Psychopathology Using Non-negative Factorization: An International Machine Learning Study.

Authors:  Ji Chen; Kaustubh R Patil; Susanne Weis; Kang Sim; Thomas Nickl-Jockschat; Juan Zhou; André Aleman; Iris E Sommer; Edith J Liemburg; Felix Hoffstaedter; Ute Habel; Birgit Derntl; Xiaojin Liu; Jona M Fischer; Lydia Kogler; Christina Regenbogen; Vaibhav A Diwadkar; Jeffrey A Stanley; Valentin Riedl; Renaud Jardri; Oliver Gruber; Aristeidis Sotiras; Christos Davatzikos; Simon B Eickhoff
Journal:  Biol Psychiatry       Date:  2019-09-23       Impact factor: 12.810

8.  Patients With First-Episode Psychosis are Not a Homogeneous Population: Implications for Treatment.

Authors:  Angelo Cocchi; Giorgio Cerati; Antonio Lora; Anna Meneghelli; Emiliano Monzani; Mauro Percudani; Lorenzo Petrovich; Fiorino Mirabella; Angelo Picardi; Antonio Preti
Journal:  Clin Pract Epidemiol Ment Health       Date:  2014-02-07

9.  Physical Activity in Schizophrenia is Higher in the First Episode than in Subsequent Ones.

Authors:  Sebastian Walther; Katharina Stegmayer; Helge Horn; Nadja Razavi; Thomas J Müller; Werner Strik
Journal:  Front Psychiatry       Date:  2015-01-05       Impact factor: 4.157

10.  Mechanisms Underlying Auditory Hallucinations-Understanding Perception without Stimulus.

Authors:  Derek K Tracy; Sukhwinder S Shergill
Journal:  Brain Sci       Date:  2013-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.